Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Semaglutide

Ozempic, Rybelsus, Wegovy

Quick Stats
Studies 78
Trials 100
Unknown OBSERVATIONAL NCT06182618

Retrospective Analysis for Patients With Metabolic Syndrome

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

The incidence of metabolic syndrome and related diseases is gradually increasing, and diet and medication are currently common outpatient treatment methods. This study retrospectively analyzes the clinical data of patients with metabolic syndrome and related diseases who have visited our outpatient department in the past 10 years, compares the therapeutic effects of different treatment methods on their blood glucose, blood lipids, blood pressure, uric acid, and body composition, and provides evidence support for clinical treatment.

Interventions

Name: dietary, semaglutide or/and metformin
Type: OTHER
Description: patients were prescribed dietary and pharmaceuticals for weight loss

Primary Outcomes

Measure: weight
TimeFrame: 0month/1month/2months/3 months
Description: Weight was measured through multi-frequency bioelectrical impedance analysis InBody 720 (Bio Space Co., Seoul, Korea) at various time points

Trial Information

NCT ID

NCT06182618

Status

Unknown

Study Type

OBSERVATIONAL

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Last Updated

December 15, 2025